3-149761497-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144960.3(ANKUB1):āc.1622A>Gā(p.Glu541Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00135 in 1,551,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001144960.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKUB1 | NM_001144960.3 | c.1622A>G | p.Glu541Gly | missense_variant | 6/6 | ENST00000446160.7 | NP_001138432.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKUB1 | ENST00000446160.7 | c.1622A>G | p.Glu541Gly | missense_variant | 6/6 | 5 | NM_001144960.3 | ENSP00000387907 | P1 | |
ANKUB1 | ENST00000484019.1 | c.*1392A>G | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 1 | ENSP00000420428 |
Frequencies
GnomAD3 genomes AF: 0.000946 AC: 144AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000806 AC: 124AN: 153928Hom.: 0 AF XY: 0.000882 AC XY: 72AN XY: 81674
GnomAD4 exome AF: 0.00140 AC: 1955AN: 1399052Hom.: 0 Cov.: 29 AF XY: 0.00131 AC XY: 904AN XY: 690038
GnomAD4 genome AF: 0.000945 AC: 144AN: 152358Hom.: 0 Cov.: 33 AF XY: 0.000913 AC XY: 68AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2022 | The c.1622A>G (p.E541G) alteration is located in exon 6 (coding exon 6) of the ANKUB1 gene. This alteration results from a A to G substitution at nucleotide position 1622, causing the glutamic acid (E) at amino acid position 541 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at